Print Page | Close Window

Watson Pharmaceuticals To Present At Merrill Lynch Pharmaceuticals Healthcare Conference

CORONA, CA – February 1, 2001 – Watson Pharmaceuticals, Inc. (NYSE: WPI) announced that a live webcast of its presentation scheduled for Tuesday, February 6, 2001, at 4:10 p.m. E.S.T. (1:10 p.m. P.S.T.) at the Merrill Lynch Pharmaceuticals Healthcare Conference at the Grand Hyatt Hotel in New York, NY, may be accessed via the internet.

The URL for the webcast will be http://events.mlresearchmedia.com/ml/pharmedbio. On the day of the webcast, this link will have a menu that will allow any visitor to the website access to Watson’s presentation. A recording of the webcast may be accessed for three months after the event at the same URL.

This press release may contain forward-looking statements relating to Watson’s future business performance, which involve risks and uncertainties that cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, among others, those detailed in Watson’s Securities and Exchange Commission filings.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is engaged in the development, manufacture and sale of proprietary and off-patent pharmaceutical products. Watson pursues a strategy of generating revenue through established proprietary and off-patent business, capitalizing on its proven ability to support the development and commercialization of a broad range of proprietary and off-patent pharmaceutical products.

This and past press releases of Watson Pharmaceuticals, Inc. are available at Watson’s web site at www.watsonpharm.com. In addition, press releases are available through PR Newswire’s Company On-Call fax service at (800) 758-5804, extension 112856, and at www.prnewswire.com.

###

CONTACTS:
Watson Pharmaceuticals, Inc.
Sara Swee
Director, Corporate Communications
(909) 270-1400

Morgen-Walke Associates, Inc.
Jim Byers (Investors)
Christopher Katis (Press)
(415) 296-7383